Travere Therapeutics (TVTX) PT Raised to $54 at Guggenheim
(Updated - April 14, 2026 7:08 AM EDT)
Guggenheim analyst Vamil Divan raised the price target on Travere Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Guggenheim analyst Vamil Divan raised the price target on Travere Therapeutics ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
